Cre-LoxP-regulated expression of monoclonal antibodies driven by an ovalbumin promoter in primary oviduct cells
2011

Improving Antibody Production in Chicken Oviduct Cells

publication Evidence: moderate

Author Information

Author(s): Oishi Isao, Kim Sungtae, Yoshii Kyoko, Esteban Concepcion Rodriguez, Izpisua Belmonte Juan Carlos

Primary Institution: Health Research Institute, National Institute of Advanced Industrial Science and Technology

Hypothesis

Can the Cre/loxP system enhance the expression of monoclonal antibodies in chicken oviduct cells using an ovalbumin promoter?

Conclusion

The Cre/loxP-based system significantly increases the production of therapeutic monoclonal antibodies in chicken oviduct cells.

Supporting Evidence

  • The expression level of hIgG in oviduct cells was increased 40-fold compared to that induced directly by the ovalbumin promoter.
  • hIgG was not induced by the ovalbumin promoter-driven Cre in chicken embryonic fibroblast cells.
  • The study demonstrated that the Cre/loxP system could enhance protein production specifically in oviduct cells.

Takeaway

Scientists found a way to make chickens produce more medicine by using a special system that helps control when the medicine is made in the chicken's egg whites.

Methodology

The study used a Cre/loxP-mediated conditional excision system to enhance the expression of humanized immunoglobulin G in chicken oviduct cells.

Limitations

The effectiveness of the system in transgenic chickens remains to be demonstrated.

Digital Object Identifier (DOI)

10.1186/1472-6750-11-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication